Knockdown of TUG1 mitigated cardiac hypertrophy and decreased cardiac fibrosis in vivo, and attenuated the hypertrophic response in cardiomyocytes treated with high glucose in vitro (86, 87). The gene discussed is TUG1; the disease is cardiac hypertrophy.